BiotechTube
Home/Pipeline/Biosimilar mAbs

Biosimilar mAbs

Various

Discovery/PreclinicalActive

Key Facts

Indication
Various
Phase
Discovery/Preclinical
Status
Active
Company
Ipca Laboratories

About Ipca Laboratories

Ipca Laboratories is a mission-driven, fully integrated global pharmaceutical company dedicated to advancing healthcare through quality, affordable medicines. Its strategic achievements include establishing world-leading API manufacturing capabilities, securing approvals from stringent global regulators, and building a robust international footprint. The company's core strategy hinges on vertical integration for cost and supply chain control, therapeutic area dominance, and a growing R&D focus on novel drugs and biologics to drive future growth.

View full company profile

Therapeutic Areas

Anti-malarialsAnalgesics/PainAnti-inflammatoryCardiovascularAnti-diabeticsAnti-infectivesHair Care

Other Various Drugs

DrugCompanyPhase
New Generic ApprovalsChina SXT PharmaceuticalsApplication Submitted / BE Stage
New Dosage Form DevelopmentUniverse PharmaceuticalsDevelopment
New TCM Formula RegistrationUniverse PharmaceuticalsDevelopment
Bag APIsChemWerthApproved
Oral APIsChemWerthApproved
Companion Diagnostics DevelopmentKiffik BiomedicalPre-clinical
Portfolio of Complex Generics & 505(b)(2) ProductsAlvogenApproved/Commercial
Portfolio of 40+ productsPraxgen PharmaceuticalsDevelopment
Generic Product PipelineLannettANDA Development
Drug Repositioning ServiceBiovistaService
Custom Control DevelopmentAnchor MolecularDevelopment/Commercial
Portfolio from Steriscience PartnershipArmas PharmaceuticalsANDA Development/Filing